DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced activities highlighting the latest experience with the TRYTON Side Branch Stent at the annual Transcatheter Cardiovascular Therapeutics (TCT) 2011 conference taking place Nov. 7-11 in San Francisco.
